2505: Q&A with Molecule Group CEO Michael Kraftman, and CFO Keith Butcher

Zak Mir talks to Michael Kraftman, CEO, and Keith Butcher, CFO, of Molecule Group, as they explain the recent name change from Vulcan Two. Also discussed are the roll up strategy of the regulated UK ePharmacy and interim results.